Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways
- PMID: 17610867
- DOI: 10.1016/j.ejphar.2007.05.021
Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways
Abstract
Glucocorticoids are commonly used for treatment of chronic inflammatory diseases, while a number of patients show insensitivity to glucocorticoid treatment. The molecular basis of these individual differences in glucocorticoid pharmacodynamics has little been taken into account. Here we focus on the implication of Staphylococcus aureus-producing superantigen, such as toxic shock syndrome toxin-1 (TSST-1), in the glucocorticoid sensitivity of human peripheral blood mononuclear cells and cell-response to glucocorticoid to produce a transcript for FK506-binding protein (FKBP51). Peripheral blood mononuclear cell-sensitivity to glucocorticoid was assessed by a cell proliferation test. FKBP51mRNA expressions were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR). We also compared concentrations of various cytokines produced in culture supernatant between concanavalin A- and TSST-1-stimulated peripheral blood mononuclear cells using a cytometric beads array. Mitogen-activated protein kinase (MAPK) phosphorylation activity in peripheral blood mononuclear cells stimulated with concanavalin A and TSST-1 was analyzed by a cell-based ELISA. Prednisolone markedly inhibited concanavalin A-induced peripheral blood mononuclear cell proliferation, but they scarcely inhibited TSST-1-induced peripheral blood mononuclear cell proliferation. The mean (S.D.) of immunosuppressant concentrations that would give 50% (IC(50)) values for prednisolone in concanavalin A-stimulated peripheral blood mononuclear cells was 52.6 (54.2) ng/ml, which was significantly lower than that in TSST-1-stimulated peripheral blood mononuclear cells, i.e., 574.2 (817.0) ng/ml (P<0.001). TSST-1-stimulated peripheral blood mononuclear cells for 48 h attenuated prednisolone-induced FKBP51mRNA expressions concomitantly with decreased sensitivity to the anti-proliferative effects of prednisolone. Concentrations of interleukin-2 (IL-2) produced from TSST-1-stimulated peripheral blood mononuclear cells were significantly higher than that from peripheral blood mononuclear cells stimulated with concanavalin A (P<0.0001). Both concanavalin A and TSST-1 enhanced the phosphorylation of extracellular signal-regulated kinase (ERK) and p38, whereas the level of c-jun terminal kinase (JNK) phosphorylation was only increased by TSST-1-stimulation in peripheral blood mononuclear cells. Furthermore, the decreased FKBP51mRNA by TSST-1was found to be recovered by JNK and mitogen-activated protein kinase (MEK)/ERK inhibitors. Our data suggest that TSST-1 reduces activity of glucocorticoid in peripheral blood mononuclear cells by JNK activation and subsequent production of IL-2. Therefore, JNK might be an attractive target for overcoming glucocorticoid insensitivity induced by TSST-1 in peripheral blood mononuclear cells.
Similar articles
-
Azithromycin suppresses proliferation, interleukin production and mitogen-activated protein kinases in human peripheral-blood mononuclear cells stimulated with bacterial superantigen.J Pharm Pharmacol. 2011 Oct;63(10):1320-6. doi: 10.1111/j.2042-7158.2011.01343.x. Epub 2011 Aug 19. J Pharm Pharmacol. 2011. PMID: 21899548
-
Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.Transpl Immunol. 2007 Apr;17(3):187-92. doi: 10.1016/j.trim.2006.10.003. Epub 2006 Nov 20. Transpl Immunol. 2007. PMID: 17331845
-
Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis.Int Immunopharmacol. 2006 Jun;6(6):924-34. doi: 10.1016/j.intimp.2006.01.001. Epub 2006 Jan 30. Int Immunopharmacol. 2006. PMID: 16644478
-
Novel repression of the glucocorticoid receptor by anthrax lethal toxin.Ann N Y Acad Sci. 2004 Jun;1024:9-23. doi: 10.1196/annals.1321.003. Ann N Y Acad Sci. 2004. PMID: 15265771 Review.
-
Therapeutic approaches to superantigen-based diseases: a review.J Mol Recognit. 2003 Mar-Apr;16(2):91-101. doi: 10.1002/jmr.612. J Mol Recognit. 2003. PMID: 12720278 Review.
Cited by
-
The glucocorticoid receptor: a revisited target for toxins.Toxins (Basel). 2010 Jun;2(6):1357-80. doi: 10.3390/toxins2061357. Epub 2010 Jun 9. Toxins (Basel). 2010. PMID: 22069642 Free PMC article. Review.
-
Association of eosinophilic inflammation with FKBP51 expression in sputum cells in asthma.PLoS One. 2013 Jun 6;8(6):e65284. doi: 10.1371/journal.pone.0065284. Print 2013. PLoS One. 2013. PMID: 23762334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous